Immune Response and Tumor Microenvironment DOI

Vivek Pazhamalai,

V. T. Thanush,

P. Dharshika

и другие.

Advances in medical diagnosis, treatment, and care (AMDTC) book series, Год журнала: 2024, Номер unknown, С. 29 - 52

Опубликована: Дек. 17, 2024

Tumor formation and progression are caused by neoplastic cells, which take advantage of interfere with cellular processes that control growth, survival, division. New research emphasizes the critical role tumor microenvironment (TME) in cancer initiation metastasis, even though genetic epigenetic changes well-known malignant transformation. The influences metagenesis, angiogenesis, immune tolerance, helps cells proliferate rapidly. It also plays a origin, progression, invasion cancer. With variety roles, including matrix deposition remodeling, extensive reciprocal signaling connections crosstalk invading leukocytes, cancer-associated fibroblasts (CAFs) an essential part microenvironment. This chapter reveals origins CAFs heterogeneity CAF function, wherein it is preferable to preserve some antitumorigenic properties.

Язык: Английский

Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment DOI Open Access
Durre Aden, Niti Sureka, Samreen Zaheer

и другие.

Immunology, Год журнала: 2024, Номер unknown

Опубликована: Окт. 27, 2024

ABSTRACT Cancer is a complex and heterogeneous disease characterised by uncontrolled cell growth proliferation. One hallmark of cancer cells their ability to undergo metabolic reprogramming, which allows them sustain rapid survival. This reprogramming creates an immunosuppressive microenvironment that facilitates tumour progression evasion the immune system. In this article, we review mechanisms underlying in discuss how these alterations contribute establishment microenvironment. We also explore potential therapeutic strategies targeting vulnerabilities enhance immune‐mediated anti‐tumour responses. Trial Registration ClinicalTrials.gov identifier: NCT02044861, NCT03163667, NCT04265534, NCT02071927, NCT02903914, NCT03314935, NCT03361228, NCT03048500, NCT03311308, NCT03800602, NCT04414540, NCT02771626, NCT03994744, NCT03229278, NCT04899921

Язык: Английский

Процитировано

2

Exploring the potential impact of non-invasive modifications of the Gut Microbiome on Cancer Immunotherapy – a narrative review DOI Open Access
Adi David, Shaked Lev‐Ari

Опубликована: Янв. 8, 2024

The following narrative review embarks on a comprehensive exploration of the pivotal role played by gut microbiome within Diet-Microbiota-Immunity (DMI) tripartite, aiming to enhance anti-cancer immunotherapy efficacy. While revolutionizing cancer treatment, resistance and immune-related adverse events (irAEs) remain challenges. tumor microenvironment (TME), shaped cells, influences resistance. microbiome, influenced genetics, environment, diet, interventions, emerges as critical player in TME reshaping, thereby modulating immune responses treatment outcomes. Dietary patterns like Mediterranean caloric restriction modifications, specific nutritional components show promise influencing for better Antibiotics, disrupting microbiota diversity, may compromise efficacy. This emphasizes need tailored strategies manipulate microbial communities, regulation, improve accessibility while minimizing side effects. Ongoing studies investigate impact dietary interventions immunotherapy, pointing towards promising developments personalized care. synthesizes existing knowledge charts course future investigations, presenting holistic perspective dynamic interplay between DMI tripartite.

Язык: Английский

Процитировано

1

Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to Predict Prognosis and Immunotherapy Response DOI Creative Commons
Yun Wu, Jiaru Chen,

Riting Zhu

и другие.

Metabolites, Год журнала: 2024, Номер 14(1), С. 51 - 51

Опубликована: Янв. 13, 2024

The major liver cancer subtype is hepatocellular carcinoma (HCC). Studies have indicated that a better prognosis related to the presence of tumor-infiltrating lymphocytes (TILs) in HCC. However, molecular pathways drive immune cell variation tumor microenvironment (TME) remain poorly understood. Glycosylation (GLY)-related genes vital function pathogenesis numerous tumors, including This study aimed develop GLY/TME classifier based on glycosylation-related gene scores and provide novel prognostic model improve prediction clinical outcomes. reliability signatures was assessed using receiver operating characteristic (ROC) survival analyses verified with external datasets. Furthermore, correlation between other cells environment, signature classifier, efficacy immunotherapy were also investigated. GLY score low/TME high subgroup showed favorable therapeutic response significant differences immune-related molecules signaling mechanisms. We evaluated role demonstrated overall significance for before treatment, which may new options creating best possible approaches patients.

Язык: Английский

Процитировано

1

Mitochondrial Energy Metabolism in Carcinogenesis DOI
Natalia Kurhaluk,

Halina Tkaczenko

Interdisciplinary cancer research, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

The chapter examines and analyses scientific publications devoted to the role of mitochondria in support life transformed cells study characteristics structural functional dysfunctions mitochondria. Issues mitochondrial control cellular redox homeostasis sites reactive oxygen species (ROS) production inner membrane are considered. features reorganisation malignant tumour mechanisms reprogramming energy metabolism, increasing ROS production, adaptation conditions hypoxia metabolic stress analysed. Mitochondrial dysfunction, activation oncogenes, inactivation anti-oncogenes, cell microenvironment have a profound effect on metabolism cancer determine heterogeneity profiles between different types. importance identifying specific changes each is clear given need effectively influence its growth. Understanding dysfunction very important for studying pathophysiology many other common diseases. This gives impetus development pharmacology using as targets types effects, which can serve biochemical basis new antitumour agents. Perhaps combined use modulators agents will contribute emergence direction therapy that significantly increase effectiveness treatment patients.

Язык: Английский

Процитировано

1

Nutrition, Immune Function, and Health DOI

Samuel U. Felix,

Chiezey N. Pauline,

Yakubu Mariam

и другие.

Опубликована: Авг. 6, 2024

The role of nutrition in shaping the immune system is a critical aspect maintaining overall health, particularly during vulnerable periods like early lactation dairy cows. Various nutrients, including glucose, glutamine (Gln), and ketones, have been found to impact cell function. Gln, versatile amino acid, serves as precursor for DNA RNA synthesis, NADPH production, energy generation, all crucial responses. Gln plays pivotal cytokine synthesis phagocytosis, macrophages monocytes. Glucose essential proliferation, survival, differentiation cells, with activated cells relying on it their primary metabolic fuel. Restricting glucose uptake phagocytic has shown impair function, which highlights importance availability when mounting an effective response. Ketones, especially β-hydroxybutyrate (BHBA), associated compromised function Elevated BHBA levels can hinder chemotaxis respiratory burst activity neutrophils, potentially increases risk infections mastitis. Additionally, may lymphocyte proliferation antibody secretion further compromise defenses. Non-esterified fatty acids (NEFAs) complex effects both stimulatory inhibitory observed. NEFAs phagocyte immunoglobulin (Ig)M secretion, production. type concentration circulation determine whether they enhance or suppress Energy balance these interactions, negative (NEB) exacerbating immunosuppression. Epidemiological studies linked metabolites characteristic NEB mastitis risk, suggests that multiple blood serve better indicators than individual markers.

Язык: Английский

Процитировано

0

Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review DOI Creative Commons
Adi David, Shaked Lev‐Ari

Integrative Cancer Therapies, Год журнала: 2024, Номер 23

Опубликована: Янв. 1, 2024

The following narrative review embarks on a comprehensive exploration of the role played by gut microbiome within Diet-Microbiota-Immunity (DMI) tripartite, aiming to enhance anti-cancer immunotherapy efficacy. While revolutionizing cancer treatment, resistance and immune-related adverse events (irAEs) remain challenges. tumor microenvironment (TME), shaped cells, influences resistance. microbiome, influenced genetics, environment, diet, interventions, emerges as critical player in TME reshaping, thereby modulating immune responses treatment outcomes. Dietary patterns like Mediterranean caloric restriction modifications, specific nutritional components show promise influencing for better Antibiotics, disrupting microbiota diversity, may compromise This emphasizes need tailored strategies manipulate microbial communities, regulation, improve accessibility while minimizing side effects. Ongoing studies investigate impact dietary interventions immunotherapy, pointing toward promising developments personalized care. synthesizes existing knowledge charts course future investigations, presenting holistic perspective dynamic interplay between DMI tripartite.

Язык: Английский

Процитировано

0

Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer DOI
Salvatore Cortellino,

Margherita D’Angelo,

Massimiliano Quintiliani

и другие.

Journal of Cellular Physiology, Год журнала: 2024, Номер 240(1)

Опубликована: Сен. 8, 2024

Neoplastic transformation reprograms tumor and surrounding host cell metabolism, increasing nutrient consumption depletion in the microenvironment. Tumors uptake nutrients from neighboring normal tissues or bloodstream to meet energy anabolic demands. Tumor-induced chronic inflammation, a high-energy process, also consumes sustain its dysfunctional activities. These tumor-related metabolic physiological changes, including negatively impact systemic metabolism physiology. Furthermore, adverse effects of antitumor therapy obstruction impair endocrine, neural, gastrointestinal systems, thereby confounding status patients. alterations result decreased appetite, impaired absorption, shift catabolic metabolism. Consequently, cancer patients often suffer malnutrition, which worsens prognosis increases susceptibility secondary events. This review explores how neoplastic affects microenvironment leading poor prognosis, discusses potential strategies clinical interventions improve patient outcomes.

Язык: Английский

Процитировано

0

Metformin boosts doxorubicin efficacy and increases CD8 + T cell frequency in mouse breast cancer DOI

Elaheh Hassani,

Sahand Mozzendizaji,

Vahid Shafiei‐Irannejad

и другие.

Clinical & Translational Oncology, Год журнала: 2024, Номер unknown

Опубликована: Окт. 29, 2024

Язык: Английский

Процитировано

0

Immune Response and Tumor Microenvironment DOI

Vivek Pazhamalai,

V. T. Thanush,

P. Dharshika

и другие.

Advances in medical diagnosis, treatment, and care (AMDTC) book series, Год журнала: 2024, Номер unknown, С. 29 - 52

Опубликована: Дек. 17, 2024

Tumor formation and progression are caused by neoplastic cells, which take advantage of interfere with cellular processes that control growth, survival, division. New research emphasizes the critical role tumor microenvironment (TME) in cancer initiation metastasis, even though genetic epigenetic changes well-known malignant transformation. The influences metagenesis, angiogenesis, immune tolerance, helps cells proliferate rapidly. It also plays a origin, progression, invasion cancer. With variety roles, including matrix deposition remodeling, extensive reciprocal signaling connections crosstalk invading leukocytes, cancer-associated fibroblasts (CAFs) an essential part microenvironment. This chapter reveals origins CAFs heterogeneity CAF function, wherein it is preferable to preserve some antitumorigenic properties.

Язык: Английский

Процитировано

0